Sponsor

Region Stockholm

Sweden Lindhagensgatan 98, Vastermalm, 112 18 Stockholm, Sweden

About the sponsor

Region Stockholm supports clinical research focused on HPV infection and its associated conditions, including cervical intraepithelial neoplasia and cervical cancer. The funded work is centered on prevention and early detection within the cervical screening pathway.

HPV vaccination
HPV screening
Cervical intraepithelial neoplasia grade 2 and 3
Cervical cancer

The research activity is linked to population-level strategies for reducing persistent HPV circulation and improving prevention of cervical malignancy in women eligible for organised screening.

About Specializations

Region Stockholm runs clinical trials in conditions such as Cervix carcinoma, among others.

Cervix carcinoma

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Cervix carcinoma

Recruiting

Registered drugNo placebo

Study on HPV Vaccine and Screening to Reduce HPV Infection and Cervical Cancer in Swedish Women Aged 23-25

Registered drugNo placebo

Sweden

Participants:18–64 years · Healthy volunteers
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:Region Stockholm

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →